REVB
Price
$1.43
Change
+$0.03 (+2.14%)
Updated
Sep 26 closing price
Capitalization
3.35M
VACBF
Price
$0.20
Change
-$0.01 (-4.76%)
Updated
Sep 17 closing price
Capitalization
53.56M
Interact to see
Advertisement

REVB vs VACBF

Header iconREVB vs VACBF Comparison
Open Charts REVB vs VACBFBanner chart's image
Revelation Biosciences
Price$1.43
Change+$0.03 (+2.14%)
Volume$221.82K
Capitalization3.35M
NYKODE THERAPEUTICS AS
Price$0.20
Change-$0.01 (-4.76%)
Volume$10K
Capitalization53.56M
REVB vs VACBF Comparison Chart in %
Loading...
REVB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VACBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
REVB vs. VACBF commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is REVB is a Hold and VACBF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (REVB: $1.43 vs. VACBF: $0.20)
Brand notoriety: REVB and VACBF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: REVB: 46% vs. VACBF: 149%
Market capitalization -- REVB: $3.35M vs. VACBF: $53.56M
REVB [@Biotechnology] is valued at $3.35M. VACBF’s [@Biotechnology] market capitalization is $53.56M. The market cap for tickers in the [@Biotechnology] industry ranges from $98.9B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

REVB’s FA Score shows that 1 FA rating(s) are green whileVACBF’s FA Score has 1 green FA rating(s).

  • REVB’s FA Score: 1 green, 4 red.
  • VACBF’s FA Score: 1 green, 4 red.
According to our system of comparison, both REVB and VACBF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

REVB’s TA Score shows that 4 TA indicator(s) are bullish while VACBF’s TA Score has 0 bullish TA indicator(s).

  • REVB’s TA Score: 4 bullish, 6 bearish.
  • VACBF’s TA Score: 0 bullish, 3 bearish.
According to our system of comparison, both REVB and VACBF are a bad buy in the short-term.

Price Growth

REVB (@Biotechnology) experienced а -7.14% price change this week, while VACBF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.00%. For the same industry, the average monthly price growth was +9.18%, and the average quarterly price growth was +54.60%.

Industries' Descriptions

@Biotechnology (+4.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VACBF($53.6M) has a higher market cap than REVB($3.35M). VACBF YTD gains are higher at: -16.944 vs. REVB (-93.538). REVB has higher annual earnings (EBITDA): -8.08M vs. VACBF (-21.96M). VACBF has more cash in the bank: 70M vs. REVB (5.17M). REVB has less debt than VACBF: REVB (0) vs VACBF (3.1M). VACBF has higher revenues than REVB: VACBF (7.31M) vs REVB (0).
REVBVACBFREVB / VACBF
Capitalization3.35M53.6M6%
EBITDA-8.08M-21.96M37%
Gain YTD-93.538-16.944552%
P/E Ratio0.00N/A-
Revenue07.31M-
Total Cash5.17M70M7%
Total Debt03.1M-
TECHNICAL ANALYSIS
Technical Analysis
REVBVACBF
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
67%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
N/A
Momentum
ODDS (%)
Bearish Trend 2 days ago
67%
Bearish Trend 2 days ago
45%
MACD
ODDS (%)
Bearish Trend 2 days ago
67%
Bearish Trend 2 days ago
38%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
13%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
37%
Advances
ODDS (%)
Bullish Trend 22 days ago
71%
N/A
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
89%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
REVB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VACBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
URLOF1.070.02
+1.90%
NameSilo Technologies Corp.
SUBCY20.960.34
+1.65%
Subsea 7 S.A.
PINXY12.48N/A
N/A
Peoples Insurance Company Group China
ICHIF2.69N/A
N/A
Ichigo Group Holdings Co Ltd.
MNXXF0.04N/A
-0.39%
Manganese X Energy Corp.

REVB and

Correlation & Price change

A.I.dvisor indicates that over the last year, REVB has been loosely correlated with GNPX. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if REVB jumps, then GNPX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To REVB
1D Price
Change %
REVB100%
+2.14%
GNPX - REVB
48%
Loosely correlated
-3.48%
INM - REVB
32%
Poorly correlated
+0.46%
GLMD - REVB
31%
Poorly correlated
+1.45%
IMUX - REVB
30%
Poorly correlated
+4.54%
RLMD - REVB
29%
Poorly correlated
+9.04%
More

VACBF and

Correlation & Price change

A.I.dvisor tells us that VACBF and HYPD have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that VACBF and HYPD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VACBF
1D Price
Change %
VACBF100%
N/A
HYPD - VACBF
27%
Poorly correlated
+13.12%
SPHRY - VACBF
26%
Poorly correlated
N/A
REVB - VACBF
26%
Poorly correlated
+2.14%
VTYX - VACBF
25%
Poorly correlated
+10.78%
AURA - VACBF
22%
Poorly correlated
+4.76%
More